Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty

BACKGROUND: The use of antifibrinolytic medications in hip and knee arthroplasty reduces intraoperative blood loss and decreases transfusion rates postoperatively. Tranexamic acid (TXA) specifically has not been associated with increased thromboembolic (TE) complications, but concerns remain about t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gillette, Blake P., DeSimone, Lori J., Trousdale, Robert T., Pagnano, Mark W., Sierra, Rafael J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2012
Gaiak:
Symposium: Papers Presented at the Annual Meetings of the Knee Society
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3528901/
https://ncbi.nlm.nih.gov/pubmed/22814857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11999-012-2488-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak